2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Rabipur®: new trials by email Literature Review of Rabipur® trials Research Report on Rabipur®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults Rabipur®, Rabies mRNA vaccine CV7202 - Rabies | Phase 1 | Completed | CureVac | 53 | 2018-10-12 | 2024-12-19 |
| Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant RABIPUR®, PIKA rabies vaccine, PIKA rabies vaccine with an accelerated regimen - Rabies | Phase 1 | Completed | Yisheng Biopharma (Singapore) Pte. Ltd. | 37 | 2015-02-01 | 2016-01-15 |
Rabies (2)
CureVac (1) · Yisheng Biopharma (Singapore) Pte. Ltd. (1)
Belgium (1) · Germany (1) · Singapore (1)
Limin Wijaya (1)
PMID 28118938, PMID 33487468, PMID 37821317
2017 (1)